We expect that the combined application of these approaches in heterogeneous tumor cell lines, co-cultures of tumor cells with stroma or immune cells or in the tumor tissue itself will provide important insight into the cell-type specific activation state of the NF-κB pathway in situ. The gene discussed is NFKB1; the disease is neoplasm.